Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    22634621 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes
Conditions: Diabetes;   Type 1 Diabetes
Intervention: Drug: Alpha 1-Antitrypsin (AAT, Aralast NP)
2 Completed Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Alpha-1 Antitrypsin 40mg (AAT, Glassia®);   Drug: Alpha-1 Antitrypsin 60mg (AAT, Glassia®);   Drug: Alpha-1 Antitrypsin 80mg (AAT, Glassia®)
3 Terminated
Has Results
A Research Trial of Aralast in New Onset Diabetes (RETAIN)
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Aralast NP 45 mg dose;   Biological: Aralast NP 90 mg dose;   Biological: Aralast NP 180 mg dose

Study has passed its completion date and status has not been verified in more than two years.